Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:52:01 UTC |
---|
HMDB ID | HMDB0015554 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Alverine |
---|
Description | Alverine is a smooth muscle relaxant. Smooth muscle is a type of muscle that is not under voluntary control; it is the muscle present in places such as the gut and uterus. Alverine acts directly on the muscle in the gut, causing it to relax. This prevents the muscle spasms which occur in the gut in conditions such as irritable bowel syndrome and diverticular disease. It is used to relieve cramps or spasms of the stomach and intestines. It is also useful in treating irritable bowel syndrome (IBS) and similar conditions. It can also be used to help relieve period pain. Alverine is formulated as the citrate salt (5982-87-6). |
---|
Structure | CCN(CCCC1=CC=CC=C1)CCCC1=CC=CC=C1 InChI=1S/C20H27N/c1-2-21(17-9-15-19-11-5-3-6-12-19)18-10-16-20-13-7-4-8-14-20/h3-8,11-14H,2,9-10,15-18H2,1H3 |
---|
Synonyms | Value | Source |
---|
Alverina | ChEBI | Alverinum | ChEBI | Bis(gamma-phenylpropyl)ethylamine | ChEBI | Di(phenylpropyl)ethylamine | ChEBI | N,N-Bis(3-phenylpropyl)ethylamine | ChEBI | N-Ethyl-3,3'-diphenyldipropylamine | ChEBI | N-Ethyl-3-phenyl-N-(3-phenylpropyl)-1-propanamine | ChEBI | N-Ethyl-N-(3-phenylpropyl)benzenepropanamine | ChEBI | Phenopropamine | ChEBI | Phenpropamine | ChEBI | Bis(g-phenylpropyl)ethylamine | Generator | Bis(γ-phenylpropyl)ethylamine | Generator | N-Ethyl-bis(3-phenylpropyl)amin | HMDB | Spasmonal | HMDB | Alverine citrate | HMDB | Spasmaverine | HMDB | United drug brand OF alverine citrate | HMDB | Alverine hydrochloride | HMDB | Norgine brand OF alverine citrate | HMDB |
|
---|
Chemical Formula | C20H27N |
---|
Average Molecular Weight | 281.4351 |
---|
Monoisotopic Molecular Weight | 281.214349869 |
---|
IUPAC Name | ethylbis(3-phenylpropyl)amine |
---|
Traditional Name | alverine |
---|
CAS Registry Number | 150-59-4 |
---|
SMILES | CCN(CCCC1=CC=CC=C1)CCCC1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C20H27N/c1-2-21(17-9-15-19-11-5-3-6-12-19)18-10-16-20-13-7-4-8-14-20/h3-8,11-14H,2,9-10,15-18H2,1H3 |
---|
InChI Key | ZPFXAOWNKLFJDN-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylpropylamines. Phenylpropylamines are compounds containing a phenylpropylamine moiety, which consists of a phenyl group substituted at the third carbon by an propan-1-amine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Phenylpropylamines |
---|
Direct Parent | Phenylpropylamines |
---|
Alternative Parents | |
---|
Substituents | - Phenylpropylamine
- Aralkylamine
- Tertiary aliphatic amine
- Tertiary amine
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Amine
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.00096 g/L | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Alverine GC-MS (Non-derivatized) - 70eV, Positive | splash10-05ox-7920000000-c8c9f49008d42192bf43 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Alverine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Alverine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alverine 10V, Positive-QTOF | splash10-001i-0190000000-fa5d943a706cbacc2966 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alverine 20V, Positive-QTOF | splash10-001i-2590000000-5670c74b8576969d473e | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alverine 40V, Positive-QTOF | splash10-00kf-9700000000-0ca8414132b5d9b38dc0 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alverine 10V, Negative-QTOF | splash10-001i-0090000000-3436180aa1a55dae3c0d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alverine 20V, Negative-QTOF | splash10-001i-0190000000-4f76075ca6910a6f99f9 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alverine 40V, Negative-QTOF | splash10-0hgo-4920000000-8a9772388b6011f2db4f | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alverine 10V, Positive-QTOF | splash10-001i-0090000000-6c46192dea07b9977057 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alverine 20V, Positive-QTOF | splash10-001i-0190000000-116fee06af3fb48655ac | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alverine 40V, Positive-QTOF | splash10-0006-9710000000-88ece644f51433dcc79c | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alverine 10V, Negative-QTOF | splash10-001i-0090000000-78e4f4cb0fda655af884 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alverine 20V, Negative-QTOF | splash10-001i-0290000000-8bc76e555b532b4d0ea2 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alverine 40V, Negative-QTOF | splash10-0006-9740000000-30aa7cd1d162b50b60bc | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01616 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01616 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB01616 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 3550 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Alverine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 3678 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 518413 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Hayase M, Hashitani H, Suzuki H, Kohri K, Brading AF: Evolving mechanisms of action of alverine citrate on phasic smooth muscles. Br J Pharmacol. 2007 Dec;152(8):1228-38. Epub 2007 Oct 15. [PubMed:17934514 ]
- Ju D, Wang X, Xie Y: Dyclonine and alverine citrate enhance the cytotoxic effects of proteasome inhibitor MG132 on breast cancer cells. Int J Mol Med. 2009 Feb;23(2):205-9. [PubMed:19148544 ]
- Wittmann T, Paradowski L, Ducrotte P, Bueno L, Andro Delestrain MC: Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2010 Mar;31(6):615-24. doi: 10.1111/j.1365-2036.2009.04216.x. Epub 2009 Dec 10. [PubMed:20003095 ]
- Spasmonal Package Insert [Link]
|
---|